Circulating Tumor Cells for Hepatocellular Carcinoma

Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma

NCT04973098 ·Status: UNKNOWN ·Phase: PHASE1

Prospective Liver Study

NCT01539993 ·Status: COMPLETED

Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT06540508 ·Status: ENROLLING_BY_INVITATION

Recurrent Liver Cancer: Reconceptualization and Reevaluation

NCT06430983 ·Status: RECRUITING

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

NCT03672305 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

NCT06365034 ·Status: RECRUITING

Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma

NCT06788353 ·Status: RECRUITING

Circulating Tumor Cells and Tumor DNA in HCC and NET

NCT02973204 ·Status: COMPLETED

Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma

NCT06632717 ·Status: RECRUITING ·Phase: PHASE2

Primary Liver Cancer Cohort of South China

NCT03297255 ·Status: RECRUITING

The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma

NCT05573217 ·Status: UNKNOWN

Protein Biomarker in Hepatocellular Carcinoma

NCT00465842 ·Status: TERMINATED

Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers

NCT05278195 ·Status: UNKNOWN

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

NCT05242237 ·Status: UNKNOWN

Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers

NCT05622825 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

a Cohort Study (Gut Microbiota and HCC)

NCT06557213 ·Status: NOT_YET_RECRUITING

Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization

NCT00834028 ·Status: COMPLETED

A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

NCT07117279 ·Status: NOT_YET_RECRUITING

Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

NCT05184400 ·Status: RECRUITING

Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC

NCT02568748 ·Status: UNKNOWN ·Phase: PHASE3

Observational Study on Patients With Hepatocellular Carcinoma (HCC)

NCT04021056 ·Status: UNKNOWN

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

NCT05788835 ·Status: RECRUITING ·Phase: NA

Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization

NCT00630240 ·Status: COMPLETED

Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma

NCT01833299 ·Status: COMPLETED ·Phase: PHASE3

Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma

NCT00911196 ·Status: COMPLETED